Antifungal activity of natural products is being studied widely. Saponins are known to be antifungal and antibacterial. We have isolated eight steroid saponins from
Tribulus terrestris L., namely TTS-8, TTS-9, TTS-10, TTS-11, TTS-12, TTS-13, TTS-14 and TTS-15. TTS-12 and TTS-15 were identified as tigogenin-3-
O-β-
D-xylopyranosyl(1→2)-[β-
D-xylopyranosyl(1→3)]-β-
D-glucopyranosyl(1→4)-[α-
L-rhamnopyranosyl(1→2)]-β-
D-galactopyranoside and tigogenin-3-
O-β-
D-glucopyranosyl(1→2)-[β-
D-xylopyranosyl(1→3)]-β-
D-glucopyranosyl(1→4)-β-
D-galactopyranoside, respectively. The
in vitro antifungal activities of the eight saponins against six fluconazole-resistant yeasts,
Candida albicans,
Candida glabrata,
Candida parapsilosis,
Candida tropicalis,
Candida krusei, and
Cryptococcus neoformans were studied using microbroth dilution assay. The results showed that TTS-12 and TTS-15 were very effective against several pathogenic candidal species and
C. neoformans in vitro. It is noteworthy that TTS-12 and TTS-15 were very active against fluconazole-resistant
C. albicans (MIC
80=4.4, 9.4 μg/ml),
C. neoformans (MIC
80=10.7, 18.7 μg/ml) and inherently resistant
C. krusei (MIC
80=8.8, 18.4 μg/ml). So
in vivo activity of TTS-12 in a vaginal infection model with fluconazole-resistant
C. albicans was studied in particular. Our studies revealed TTS-12 also showed
in vivo activities against fluconazole-resistant yeasts. In conclusion, steroid saponins TTS-12 and TTS-15 from
Tribulus terrestris L. have significant
in vitro antifungal activity against fluconazole-resistant fungi, especially TTS-12 also showed
in vivo activity against fluconazole-resistant
C. albicans.
View full abstract